Reding Kerryn W, Cheng Richard K, Vasbinder Alexi, Ray Roberta M, Barac Ana, Eaton Charles B, Saquib Nazmus, Shadyab Aladdin H, Simon Michael S, Langford Dale, Branch Mary, Caan Bette, Anderson Garnet
Biobehavioral Nursing and Health Informatics Department, University of Washington School of Nursing, Seattle, Washington, USA.
Public Health Sciences Division, Fred Hutch Cancer Research Center, Seattle, Washington, USA.
JACC CardioOncol. 2022 Mar 15;4(1):53-65. doi: 10.1016/j.jaccao.2022.01.099. eCollection 2022 Mar.
Breast cancer (BC) survivors experience an increased burden of long-term comorbidities, including heart failure (HF). However, there is limited understanding of the risk for the development of HF subtypes, such as HF with preserved ejection fraction (HFpEF), in BC survivors.
This study sought to estimate the incidence of HFpEF and HF with reduced ejection fraction (HFrEF) in postmenopausal BC survivors and to identify lifestyle and cardiovascular risk factors associated with HF subtypes.
Within the Women's Health Initiative, participants with an adjudicated diagnosis of invasive BC were followed to determine the incidence of hospitalized HF, for which adjudication procedures determined left ventricular ejection fraction. We calculated cumulative incidences of HF, HFpEF, and HFrEF. We estimated HRs for risk factors in relation to HF, HFpEF, and HFrEF using Cox proportional hazards survival models.
In 2,272 BC survivors (28.6% Black and 64.9% White), the cumulative incidences of hospitalized HFpEF and HFrEF were 6.68% and 3.96%, respectively, over a median of 7.2 years (IQR: 3.6-12.3 years). For HFpEF, prior myocardial infarction (HR: 2.83; 95% CI: 1.28-6.28), greater waist circumference (HR: 1.99; 95% CI: 1.14-3.49), and smoking history (HR: 1.65; 95% CI: 1.01-2.67) were the strongest risk factors in multivariable models. With the exception of waist circumference, similar patterns were observed for HFrEF, although none were significant. In relation to those without HF, the risk of overall mortality in BC survivors with hospitalized HFpEF was 5.65 (95% CI: 4.11-7.76), and in those with hospitalized HFrEF, it was 3.77 (95% CI: 2.51-5.66).
In this population of older, racially diverse BC survivors, the incidence of HFpEF, as defined by HF hospitalizations, was higher than HFrEF. HF was also associated with an increased mortality risk. Risk factors for HF were largely similar to the general population with the exception of prior myocardial infarction for HFpEF. Notably, both waist circumference and smoking represent potentially modifiable factors.
乳腺癌(BC)幸存者长期共病负担增加,包括心力衰竭(HF)。然而,对于BC幸存者发生HF亚型(如射血分数保留的心力衰竭(HFpEF))的风险了解有限。
本研究旨在估计绝经后BC幸存者中HFpEF和射血分数降低的心力衰竭(HFrEF)的发病率,并确定与HF亚型相关的生活方式和心血管危险因素。
在女性健康倡议中,对确诊为浸润性BC的参与者进行随访,以确定住院HF的发病率,其中通过判定程序确定左心室射血分数。我们计算了HF、HFpEF和HFrEF的累积发病率。我们使用Cox比例风险生存模型估计与HF、HFpEF和HFrEF相关的危险因素的风险比(HR)。
在2272例BC幸存者中(28.6%为黑人,64.9%为白人),在中位7.2年(四分位间距:3.6 - 12.3年)期间,住院HFpEF和HFrEF的累积发病率分别为6.68%和3.96%。对于HFpEF,在多变量模型中,既往心肌梗死(HR:2.83;95%置信区间:1.28 - 6.28)、更大的腰围(HR:1.99;95%置信区间:1.14 - 3.49)和吸烟史(HR:1.65;95%置信区间:1.01 - 2.67)是最强的危险因素。除腰围外,HFrEF也观察到类似模式,尽管均无统计学意义。与无HF者相比,住院HFpEF的BC幸存者的全因死亡风险为5.65(95%置信区间:4.11 - 7.76),住院HFrEF的BC幸存者的全因死亡风险为3.77(95%置信区间:2.51 - 5.66)。
在这个年龄较大、种族多样的BC幸存者群体中,以HF住院定义的HFpEF发病率高于HFrEF。HF也与死亡风险增加相关。HF的危险因素与一般人群基本相似,但HFpEF的既往心肌梗死除外。值得注意的是,腰围和吸烟均代表潜在的可改变因素。